A genetically modified bacterial cell factory for thiamine production
AssigneeBiosyntia Aps
InventorsLuisa GRONENBERG, Bo SALOMONSEN, Matteo FERLA, Hans Jasper GENEE
Life of this patent
Estimating the term…
Loading patent…
AssigneeBiosyntia Aps
InventorsLuisa GRONENBERG, Bo SALOMONSEN, Matteo FERLA, Hans Jasper GENEE
Estimating the term…
The invention provides a genetically modified bacterium for production of thiamine; where the bacterium is characterized by a transgene encoding a thiamine monophosphate phosphatase (TMP phosphatase having EC 3.1.3.-) as well as transgenes encoding polypeptides that catalyze steps in the thiamine pathway. The genetically modified bacterium is characterized by enhanced synthesis and release of thiamine into the extracellular environment. The invention further provides a method for producing thiamine using the genetically modified bacterium of the invention; as well as the use of the genetically modified bacterium for extracellular thiamine production.
A genetically modified bacterium for production of un-phosphorylated thiamine;
Use of a transgene encoding a polypeptide having thiamine mono-phosphate phosphatase activity (E.C 3.1.3.-) to enhance un-phosphorylated thiamine production and export in an Escherichia bacterium.
Dependencies are inferred from the claim text.